Share
Market Research Report

VACCINE ADJUVANT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By TypeMineral Salt-based Adjuvant · Tensoactive Adjuvants · Adjuvant Emulsions · Liposome Adjuvants · Carbohydrate Adjuvants · Bacteria-derived Adjuvants · Virus-like Particles (VLP) · and Other Types
  • By UsageActive Immunostimulants · Carriers
  • By Disease TypeInfectious Disease and Cancer
  • By ApplicationResearch Applications and Commercial Applications
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East and Africa
  • Published In11 May 2026
  • Report CodeCMI1731
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Type
      • Market Snapshot, By Usage
      • Market Snapshot, By Disease Type
      • Market Snapshot, By Application
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Product Approval
    • Collaboration/Merge/Acquisition
    • Regulatory Landscape
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Epidemiology
    • Robust Pipeline Analysis
  4. Global Vaccine Adjuvant Market, By Type, 2021 – 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022– 2033
      • Segment Trends
    • Mineral Salt-based Adjuvant
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Tensoactive Adjuvants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Adjuvant Emulsions
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Liposome Adjuvants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Carbohydrate Adjuvants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Bacteria-derived Adjuvants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Virus-like Particles (VLP)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Other Types
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
  5. Global Vaccine Adjuvant Market, By Usage, 2021 – 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Active Immunostimulants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Carriers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
  6. Global Vaccine Adjuvant Market, By Disease Type, 2021 – 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Infectious Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
  7. Global Vaccine Adjuvant Market, By Application, 2021 – 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Research Applications
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Commercial Applications
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
  8. Global Vaccine Adjuvant Market, By Region, 2021 – 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Regions, 2022–2033
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Usage, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Usage, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Usage, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Usage, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Usage, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Usage, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Bn)
        • North Africa
        • Central Africa
        • South Africa
  9. Competitive Landscape

    • Heat Map Analysis
    • Market Share Analysis
    • Company Profile
      • Thermo Fisher Scientific Inc.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Air Liquide (Seppic)
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Pacific GeneTech Limited
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • OZ Biosciences
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Novavax Inc.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Merck & Co. Inc.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • InvivoGen
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • GlaxoSmithKline PLC
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Dynavax Technologies Corporation
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • CSL Limited
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Croda International PLC
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Vertellus
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Aphios Corporation
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Agenus Inc.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Adjuvatis
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Associated British Foods PLC (SPI Pharma Inc.)
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
    • Analyst Views
  10. Section

    • References
    • Research Methodology
    • About Us